fbpx
spot_img
Thursday, November 21, 2024
More
    spot_img

    FDA authorizes Moderna and J&J COVID vaccine boosters

    Must Read

    GNB Desk
    GNB Desk
    A global media for the latest news, entertainment, music fashion, and more.
    Follow us

    The U.S. Food and Drug Administration on Wednesday authorized booster doses of Moderna and Johnson & Johnson’s COVID-19 vaccines.

    With this authorization, anyone who has been vaccinated against Covid-19 will soon be able to choose which vaccine they would like as a booster.

    In newly issued emergency use authorizations for the Moderna and Johnson & Johnson vaccines and in a revision to the previous authorization of the Pfizer and BioNTech booster the agency made clear that people do not have to get a third dose that matches their primary series.

    “The available data suggest waning immunity in some populations who are fully vaccinated,” acting FDA Commissioner Janet Woodcock said in a statement. “The availability of these authorized boosters is important for continued protection against Covid-19 disease.” 

    In a statement FDA said that they have amended the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:

    • The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:
      • 65 years of age and older
      • 18 through 64 years of age at high risk of severe COVID-19
      • 18 through 64 years of age with frequent institutional or occupational exposure toSARS-CoV-2
    • The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.
    • The use of each of the available COVID-19 vaccines as a heterologous (or “mix and match”) booster dose in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.
    • To clarify that a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.
    Comments
    - Advertisement -spot_img
    - Advertisement -

    Latest News

    Gautam Adani Faces SEC Charges Over Massive Bribery Scheme; Wealth Declines by $15 Billion

    The Securities and Exchange Commission (SEC) has charged Gautam Adani, Sagar Adani, and Cyril Cabanes in connection with an...
    - Advertisement -spot_img

    More Articles

    - Advertisement -spot_img